FDA approves biologic for treating psoriasis in those as young as 12

| Joe Doolen

Adolescents with moderate to severe plaque psoriasis have a new option for treatment. On Oct. 13, 2017, the U.S. Food and Drug Administration (FDA) approved the use of Stelara (ustekinumab) for treating psoriasis in youth ages 12 and older. 

Stelara is a biologic (a drug made in a lab from living cells) that blocks proteins interleukin-12 and interleukin-23 from attaching to other cells, thus preventing an undesired inflammatory response – raised, red patches of skin that are often itchy and painful. Stelara is administered in two initial injections followed by an additional injection every 12 weeks, the fewest doses of any biologic option for plaque psoriasis treatment. Adolescents also must be candidates for phototherapy (skin exposure to UV light) or systemic therapy (pills or injections).

This new approval affects a crucial age group among those with plaque psoriasis, roughly one-third of whom develop the disease before age 20. In adolescents, psoriasis commonly affects the face and scalp. 

In a Phase 3 clinical trial, two-thirds of adolescents receiving injections at week 0 and week 4 showed total clearance or minimal coverage of psoriasis at week 12. Treatment involves injections every 12 weeks after the initial two. Safety findings in adolescents were consistent with those of adults.

Stelara, manufactured by Janssen, has been FDA-approved for treating adults with psoriasis and/or psoriatic arthritis since 2009.

 


Driving discovery, creating community

For more than 50 years, we’ve been driving efforts to cure psoriatic disease and improve the lives of those affected. But there’s still plenty to do! Learn how you can help our advocacy team shape the laws and policies that affect people with psoriasis and psoriatic arthritis – in your state and across the country. Help us raise funds to support research by joining Team NPF, where you can walk, run, cycle, play bingo or create your own fundraising event. If you or someone you love needs free, personalized support for living a healthier life with psoriatic disease, contact our Patient Navigation Center. And keep the National Psoriasis Foundation going strong by making a donation today. Together, we will find a cure.

Recent Advance Posts

How the voice of the patient makes a difference in your state and nationally.
Let’s get to the bottom of what it really means to be an advocate.
NPF meets with other national health care organizations about access to care...
Dial in to our summer series of advocacy calls and connect with others living...
Patients are looking to 2020 for utilization management reform in the Golden...
Clockwise from left, Brittany Duffy-Goche, Marc Boas, Pete Redding, Tami Seretti, Lisa Bayautet
How patients descended on our nation’s capitol for NPF’s annual fly-in.
Lynne Breaux Arapis
How a lack of good information mobilized one volunteer to get involved and...
Advocacy staff, patient advocates and researchers are ready to raise awareness...
When NPF advocacy brings together many voices with one mission, the results can...